Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Parecoxib market report explains the definition, types, applications, major countries, and major players of the Parecoxib market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Kelun Group
Pfizer
By Type:
Intravenous Injection
Muscle Injection
By End-User:
Hospital
Clinic
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Parecoxib Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Parecoxib Outlook to 2028- Original Forecasts
-
2.2 Parecoxib Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Parecoxib Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Parecoxib Market- Recent Developments
-
6.1 Parecoxib Market News and Developments
-
6.2 Parecoxib Market Deals Landscape
7 Parecoxib Raw Materials and Cost Structure Analysis
-
7.1 Parecoxib Key Raw Materials
-
7.2 Parecoxib Price Trend of Key Raw Materials
-
7.3 Parecoxib Key Suppliers of Raw Materials
-
7.4 Parecoxib Market Concentration Rate of Raw Materials
-
7.5 Parecoxib Cost Structure Analysis
-
7.5.1 Parecoxib Raw Materials Analysis
-
7.5.2 Parecoxib Labor Cost Analysis
-
7.5.3 Parecoxib Manufacturing Expenses Analysis
8 Global Parecoxib Import and Export Analysis (Top 10 Countries)
-
8.1 Global Parecoxib Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Parecoxib Export by Region (Top 10 Countries) (2017-2028)
9 Global Parecoxib Market Outlook by Types and Applications to 2022
-
9.1 Global Parecoxib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravenous Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Muscle Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Parecoxib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Parecoxib Market Analysis and Outlook till 2022
-
10.1 Global Parecoxib Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Parecoxib Consumption (2017-2022)
-
10.2.2 Canada Parecoxib Consumption (2017-2022)
-
10.2.3 Mexico Parecoxib Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Parecoxib Consumption (2017-2022)
-
10.3.2 UK Parecoxib Consumption (2017-2022)
-
10.3.3 Spain Parecoxib Consumption (2017-2022)
-
10.3.4 Belgium Parecoxib Consumption (2017-2022)
-
10.3.5 France Parecoxib Consumption (2017-2022)
-
10.3.6 Italy Parecoxib Consumption (2017-2022)
-
10.3.7 Denmark Parecoxib Consumption (2017-2022)
-
10.3.8 Finland Parecoxib Consumption (2017-2022)
-
10.3.9 Norway Parecoxib Consumption (2017-2022)
-
10.3.10 Sweden Parecoxib Consumption (2017-2022)
-
10.3.11 Poland Parecoxib Consumption (2017-2022)
-
10.3.12 Russia Parecoxib Consumption (2017-2022)
-
10.3.13 Turkey Parecoxib Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Parecoxib Consumption (2017-2022)
-
10.4.2 Japan Parecoxib Consumption (2017-2022)
-
10.4.3 India Parecoxib Consumption (2017-2022)
-
10.4.4 South Korea Parecoxib Consumption (2017-2022)
-
10.4.5 Pakistan Parecoxib Consumption (2017-2022)
-
10.4.6 Bangladesh Parecoxib Consumption (2017-2022)
-
10.4.7 Indonesia Parecoxib Consumption (2017-2022)
-
10.4.8 Thailand Parecoxib Consumption (2017-2022)
-
10.4.9 Singapore Parecoxib Consumption (2017-2022)
-
10.4.10 Malaysia Parecoxib Consumption (2017-2022)
-
10.4.11 Philippines Parecoxib Consumption (2017-2022)
-
10.4.12 Vietnam Parecoxib Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Parecoxib Consumption (2017-2022)
-
10.5.2 Colombia Parecoxib Consumption (2017-2022)
-
10.5.3 Chile Parecoxib Consumption (2017-2022)
-
10.5.4 Argentina Parecoxib Consumption (2017-2022)
-
10.5.5 Venezuela Parecoxib Consumption (2017-2022)
-
10.5.6 Peru Parecoxib Consumption (2017-2022)
-
10.5.7 Puerto Rico Parecoxib Consumption (2017-2022)
-
10.5.8 Ecuador Parecoxib Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Parecoxib Consumption (2017-2022)
-
10.6.2 Kuwait Parecoxib Consumption (2017-2022)
-
10.6.3 Oman Parecoxib Consumption (2017-2022)
-
10.6.4 Qatar Parecoxib Consumption (2017-2022)
-
10.6.5 Saudi Arabia Parecoxib Consumption (2017-2022)
-
10.6.6 United Arab Emirates Parecoxib Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Parecoxib Consumption (2017-2022)
-
10.7.2 South Africa Parecoxib Consumption (2017-2022)
-
10.7.3 Egypt Parecoxib Consumption (2017-2022)
-
10.7.4 Algeria Parecoxib Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Parecoxib Consumption (2017-2022)
-
10.8.2 New Zealand Parecoxib Consumption (2017-2022)
11 Global Parecoxib Competitive Analysis
-
11.1 Kelun Group
-
11.1.1 Kelun Group Company Details
-
11.1.2 Kelun Group Parecoxib Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Kelun Group Parecoxib Main Business and Markets Served
-
11.1.4 Kelun Group Parecoxib Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer Parecoxib Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Parecoxib Main Business and Markets Served
-
11.2.4 Pfizer Parecoxib Product Portfolio
-
11.2.5 Recent Research and Development Strategies
12 Global Parecoxib Market Outlook by Types and Applications to 2028
-
12.1 Global Parecoxib Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Intravenous Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Muscle Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Parecoxib Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Parecoxib Market Analysis and Outlook to 2028
-
13.1 Global Parecoxib Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Parecoxib Consumption Forecast (2022-2028)
-
13.2.2 Canada Parecoxib Consumption Forecast (2022-2028)
-
13.2.3 Mexico Parecoxib Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Parecoxib Consumption Forecast (2022-2028)
-
13.3.2 UK Parecoxib Consumption Forecast (2022-2028)
-
13.3.3 Spain Parecoxib Consumption Forecast (2022-2028)
-
13.3.4 Belgium Parecoxib Consumption Forecast (2022-2028)
-
13.3.5 France Parecoxib Consumption Forecast (2022-2028)
-
13.3.6 Italy Parecoxib Consumption Forecast (2022-2028)
-
13.3.7 Denmark Parecoxib Consumption Forecast (2022-2028)
-
13.3.8 Finland Parecoxib Consumption Forecast (2022-2028)
-
13.3.9 Norway Parecoxib Consumption Forecast (2022-2028)
-
13.3.10 Sweden Parecoxib Consumption Forecast (2022-2028)
-
13.3.11 Poland Parecoxib Consumption Forecast (2022-2028)
-
13.3.12 Russia Parecoxib Consumption Forecast (2022-2028)
-
13.3.13 Turkey Parecoxib Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Parecoxib Consumption Forecast (2022-2028)
-
13.4.2 Japan Parecoxib Consumption Forecast (2022-2028)
-
13.4.3 India Parecoxib Consumption Forecast (2022-2028)
-
13.4.4 South Korea Parecoxib Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Parecoxib Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Parecoxib Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Parecoxib Consumption Forecast (2022-2028)
-
13.4.8 Thailand Parecoxib Consumption Forecast (2022-2028)
-
13.4.9 Singapore Parecoxib Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Parecoxib Consumption Forecast (2022-2028)
-
13.4.11 Philippines Parecoxib Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Parecoxib Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Parecoxib Consumption Forecast (2022-2028)
-
13.5.2 Colombia Parecoxib Consumption Forecast (2022-2028)
-
13.5.3 Chile Parecoxib Consumption Forecast (2022-2028)
-
13.5.4 Argentina Parecoxib Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Parecoxib Consumption Forecast (2022-2028)
-
13.5.6 Peru Parecoxib Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Parecoxib Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Parecoxib Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Parecoxib Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Parecoxib Consumption Forecast (2022-2028)
-
13.6.3 Oman Parecoxib Consumption Forecast (2022-2028)
-
13.6.4 Qatar Parecoxib Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Parecoxib Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Parecoxib Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Parecoxib Consumption Forecast (2022-2028)
-
13.7.2 South Africa Parecoxib Consumption Forecast (2022-2028)
-
13.7.3 Egypt Parecoxib Consumption Forecast (2022-2028)
-
13.7.4 Algeria Parecoxib Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Parecoxib Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Parecoxib Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Parecoxib
-
Figure of Parecoxib Picture
-
Table Global Parecoxib Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Parecoxib Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Intravenous Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Muscle Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Parecoxib Consumption by Country (2017-2022)
-
Table North America Parecoxib Consumption by Country (2017-2022)
-
Figure United States Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Canada Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Mexico Parecoxib Consumption and Growth Rate (2017-2022)
-
Table Europe Parecoxib Consumption by Country (2017-2022)
-
Figure Germany Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure UK Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Spain Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Belgium Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure France Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Italy Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Denmark Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Finland Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Norway Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Sweden Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Poland Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Russia Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Turkey Parecoxib Consumption and Growth Rate (2017-2022)
-
Table APAC Parecoxib Consumption by Country (2017-2022)
-
Figure China Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Japan Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure India Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Thailand Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Singapore Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Philippines Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Parecoxib Consumption and Growth Rate (2017-2022)
-
Table South America Parecoxib Consumption by Country (2017-2022)
-
Figure Brazil Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Colombia Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Chile Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Argentina Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Peru Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Parecoxib Consumption and Growth Rate (2017-2022)
-
Table GCC Parecoxib Consumption by Country (2017-2022)
-
Figure Bahrain Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Oman Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Qatar Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Parecoxib Consumption and Growth Rate (2017-2022)
-
Table Africa Parecoxib Consumption by Country (2017-2022)
-
Figure Nigeria Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure South Africa Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Egypt Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure Algeria Parecoxib Consumption and Growth Rate (2017-2022)
-
Table Oceania Parecoxib Consumption by Country (2017-2022)
-
Figure Australia Parecoxib Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Parecoxib Consumption and Growth Rate (2017-2022)
-
Table Kelun Group Company Details
-
Table Kelun Group Parecoxib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kelun Group Parecoxib Main Business and Markets Served
-
Table Kelun Group Parecoxib Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Parecoxib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Parecoxib Main Business and Markets Served
-
Table Pfizer Parecoxib Product Portfolio
-
Figure Global Intravenous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Muscle Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parecoxib Consumption Forecast by Country (2022-2028)
-
Table North America Parecoxib Consumption Forecast by Country (2022-2028)
-
Figure United States Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Parecoxib Consumption Forecast by Country (2022-2028)
-
Figure Germany Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Parecoxib Consumption Forecast by Country (2022-2028)
-
Figure China Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Parecoxib Consumption Forecast by Country (2022-2028)
-
Figure Brazil Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Parecoxib Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Parecoxib Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Parecoxib Consumption Forecast by Country (2022-2028)
-
Figure Australia Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Parecoxib Consumption Forecast and Growth Rate (2022-2028)
-
